Matthew D. Ronsheim

CNS pipeline · person

Matthew D. Ronsheim, PhD

Chief Operating Officer of Xenon Pharmaceuticals and a member of the senior executive team, leading Chemistry, Manufacturing and Controls (CMC), Program Management and Quality Assurance.

  • 1 company

Courtesy Xenon Pharmaceuticals

Current roles

Appears with

People sharing a company with Matthew.

People and affiliation data assembled from public company disclosures, SEC filings, and conference materials — every record source-cited under psychiatrist-authored guardrails.